Health Catalyst Revenue 2018-2025 | HCAT

Health Catalyst revenue from 2018 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Health Catalyst Annual Revenue
(Millions of US $)
2024 $307
2023 $296
2022 $276
2021 $242
2020 $189
2019 $155
2018 $113
2017 $73
Health Catalyst Quarterly Revenue
(Millions of US $)
2025-09-30 $76
2025-06-30 $81
2025-03-31 $79
2024-12-31 $80
2024-09-30 $76
2024-06-30 $76
2024-03-31 $75
2023-12-31 $75
2023-09-30 $74
2023-06-30 $73
2023-03-31 $74
2022-12-31 $69
2022-09-30 $68
2022-06-30 $71
2022-03-31 $68
2021-12-31 $65
2021-09-30 $62
2021-06-30 $60
2021-03-31 $56
2020-12-31 $53
2020-09-30 $47
2020-06-30 $43
2020-03-31 $45
2019-12-31 $44
2019-09-30 $39
2019-06-30 $37
2019-03-31 $35
2018-12-31
2018-09-30 $33
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.174B $0.307B
Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.335B 44.34
Tempus AI (TEM) United States $12.322B 0.00
Doximity (DOCS) United States $8.258B 34.00
Hims & Hers Health (HIMS) United States $7.362B 59.89
IRhythm Technologies (IRTC) United States $5.445B 0.00
Hinge Health (HNGE) United States $3.816B 0.00
Privia Health (PRVA) United States $2.881B 180.15
Inspire Medical Systems (INSP) United States $2.816B 46.60
Heartflow (HTFL) United States $2.707B 0.00
10x Genomics (TXG) United States $2.506B 0.00
Omnicell (OMCL) United States $2.297B 46.96
Azenta (AZTA) United States $1.726B 70.83
Enovis (ENOV) United States $1.541B 8.09
Schrodinger (SDGR) United States $1.373B 0.00
Clover Health Investments (CLOV) United States $1.364B 0.00
Butterfly Network (BFLY) United States $1.079B 0.00
Phreesia (PHR) United States $1.033B 0.00
Fulgent Genetics (FLGT) United States $0.870B 0.00
Talkspace (TALK) United States $0.661B 133.00
Standard BioTools (LAB) United States $0.581B 0.00
Claritev (CTEV) United States $0.528B 0.00
Evolent Health (EVH) United States $0.463B 0.00
Zepp Health (ZEPP) Netherlands $0.387B 0.00
Carlsmed (CARL) United States $0.384B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.348B 0.00
TruBridge (TBRG) United States $0.328B 15.06
Senseonics Holdings (SENS) United States $0.291B 0.00
CapsoVision (CV) United States $0.281B 0.00
KORU Medical Systems (KRMD) United States $0.273B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.204B 0.00
Nyxoah SA (NYXH) Belgium $0.173B 0.00
MDxHealth SA (MDXH) Belgium $0.162B 0.00
CareCloud (CCLD) United States $0.125B 6.84
Outset Medical (OM) United States $0.101B 0.00
EUDA Health Holdings (EUDA) Singapore $0.092B 0.00
HeartBeam (BEAT) United States $0.088B 0.00
Pulmonx (LUNG) United States $0.082B 0.00
American Well (AMWL) United States $0.081B 0.00
Retrieve Medical Holdings (RMHI) United States $0.068B 0.00
NetraMark Holdings (AINMF) Canada $0.067B 0.00
Precipio (PRPO) United States $0.046B 0.00
Evaxion - (EVAX) Denmark $0.043B 0.00
111 (YI) China $0.032B 0.00
Lunai Bioworks (LNAI) United States $0.022B 0.00
P3 Health Partners (PIII) United States $0.021B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
Zhongchao (ZCMD) China $0.014B 0.00
HeartSciences (HSCS) United States $0.010B 0.00
Bullfrog AI Holdings (BFRG) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
Movano (MOVE) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00